Insider · CIK 0001870825
David Badawi
Files at SGHT (Sight Sciences, Inc.). First filing Jan 6, 2025, latest Oct 5, 2026.
David Badawi files SEC Form 4 as officer and director at SGHT (Sight Sciences, Inc.). Since Jan 6, 2025, David Badawi has reported 0 open-market buys worth $0 and 10 open-market sells worth $300k, the latest filed on Oct 5, 2026.
A track record needs three past buys with six months of prices behind them; David Badawi has 0, so none is measured yet.
The newest scored trade: sold $71k of SGHT on Oct 1, 2026, filed Oct 5, 2026, scored 18 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 4 sells worth $204k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
SGHT: Sight Sciences, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 18Weak | Sight Sciences, Inc. | $71k 7,797 shares | -0% | +182% from low-4% from high | |
| 15Weak | Sight Sciences, Inc. | $28k 8,168 shares | -0% | +68% from low-61% from high | |
| 15Weak | Sight Sciences, Inc. | $32k 4,836 shares | -0% | +210% from low-29% from high | |
| 38Weak | Sight Sciences, Inc. | $73k 9,660 shares | -1% | +258% from low-17% from high | |
| 30Weak | Sight Sciences, Inc. | $20k 6,033 shares | -0% | +57% from low-47% from high | |
| 30Weak | Sight Sciences, Inc. | $24k 5,679 shares | -0% | +101% from low-39% from high | |
| 30Weak | Sight Sciences, Inc. | $14k 5,980 shares | -0% | 0% from low-67% from high | |
| 30Weak | Sight Sciences, Inc. | $15k 5,423 shares | -0% | - | |
| 30Weak | Sight Sciences, Inc. | $12k 3,829 shares | -0% | - | |
| 30Weak | Sight Sciences, Inc. | $11k 3,111 shares | -0% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Oct 3, 2025 | SGHT Sight Sciences, Inc. | 6,033 0.01% of outstanding | $20k | Oct 3, 2025 | $24k |
| Jul 3, 2025 | SGHT Sight Sciences, Inc. | 5,679 0.01% of outstanding | $24k | Jul 3, 2025 | none |
| Apr 1, 2025 | SGHT Sight Sciences, Inc. | 5,980 0.01% of outstanding | $14k | Apr 1, 2025 | $39k |
| Jan 17, 2025 | SGHT Sight Sciences, Inc. | 5,423 0.01% of outstanding | $15k | Jan 17, 2025 | $23k |
| Jan 8, 2025 | SGHT Sight Sciences, Inc. | 3,829 0.01% of outstanding | $12k | Jan 8, 2025 | $11k |
| Jan 3, 2025 | SGHT Sight Sciences, Inc. | 3,111 0.01% of outstanding | $11k | Jan 3, 2025 | none |
Transactions
Every row this insider has filed, 21 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | SGHT Sight Sciences, Inc. | SOpen-market sale Common Stock10b5-1 | -7,797 | $9.05 | $71k | 1,975,075 | 8 d ago |
| Apr 2, 2026 | SGHT Sight Sciences, Inc. | SOpen-market sale Common Stock10b5-1 | -8,168 | $3.48 | $28k | 1,990,290 | Apr 3, 2026 |
| Feb 19, 2026 | SGHT Sight Sciences, Inc. | MOption exercise Common Stock | +21,270 | $0.23 | $4,892 | 1,998,458 | Feb 23, 2026 |
| Feb 19, 2026 | SGHT Sight Sciences, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -21,270 | $0.00 | $0 | 0 | Feb 23, 2026 |
| Feb 3, 2026 | SGHT Sight Sciences, Inc. | AGrant or award Common Stock | +64,915 | $0.00 | $0 | 1,977,188 | Feb 5, 2026 |
| Jan 16, 2026 | SGHT Sight Sciences, Inc. | SOpen-market sale Common Stock10b5-1 | -4,836 | $6.62 | $32k | 1,912,273 | Jan 21, 2026 |
| Jan 2, 2026 | SGHT Sight Sciences, Inc. | SOpen-market sale Common Stock | -2,914 | $7.43 | $22k | 1,923,855 | Jan 6, 2026 |
| Jan 5, 2026 | SGHT Sight Sciences, Inc. | SOpen-market sale Common Stock | -3,051 | $7.82 | $24k | 1,920,804 | Jan 6, 2026 |
| Jan 6, 2026 | SGHT Sight Sciences, Inc. | SOpen-market sale Common Stock | -3,695 | $7.48 | $28k | 1,917,109 | Jan 6, 2026 |
| Dec 26, 2025 | SGHT Sight Sciences, Inc. | MOption exercise Common Stock | +21,270 | $0.23 | $4,892 | 1,926,769 | Dec 30, 2025 |
| Sep 21, 2022 | SGHT Sight Sciences, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -40,000 | $0.00 | $0 | 42,540 | Dec 30, 2025 |
| Dec 26, 2025 | SGHT Sight Sciences, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -21,270 | $0.00 | $0 | 21,270 | Dec 30, 2025 |
| Oct 3, 2025 | SGHT Sight Sciences, Inc. | SOpen-market sale Common Stock | -6,033 | $3.27 | $20k | 1,864,992 | Oct 3, 2025 |
| Jul 17, 2025 | SGHT Sight Sciences, Inc. | MOption exercise Common Stock | +40,000 | $0.12 | $4,800 | 1,871,025 | Jul 18, 2025 |
| Jul 17, 2025 | SGHT Sight Sciences, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -40,000 | $0.00 | $0 | 0 | Jul 18, 2025 |
| Jul 3, 2025 | SGHT Sight Sciences, Inc. | SOpen-market sale Common Stock | -5,679 | $4.17 | $24k | 1,831,025 | Jul 7, 2025 |
| Apr 1, 2025 | SGHT Sight Sciences, Inc. | SOpen-market sale Common Stock | -5,980 | $2.30 | $14k | 1,836,704 | Apr 3, 2025 |
| Mar 11, 2025 | SGHT Sight Sciences, Inc. | AGrant or award Common Stock | +98,566 | $0.00 | $0 | 1,842,684 | Mar 13, 2025 |
| Jan 17, 2025 | SGHT Sight Sciences, Inc. | SOpen-market sale Common Stock | -5,423 | $2.78 | $15k | 1,744,118 | Jan 21, 2025 |
| Jan 8, 2025 | SGHT Sight Sciences, Inc. | SOpen-market sale Common Stock | -3,829 | $3.26 | $12k | 1,749,541 | Jan 10, 2025 |
| Jan 3, 2025 | SGHT Sight Sciences, Inc. | SOpen-market sale Common Stock | -3,111 | $3.52 | $11k | 1,753,370 | Jan 6, 2025 |
Questions about David Badawi
Answered from the filings on this page, as of the latest one.
Is David Badawi buying or selling?
In the last 12 months David Badawi reported 0 open-market buys worth $0 and 4 open-market sells worth $204k on SEC Form 4; the latest was sold $71k of SGHT on Oct 1, 2026. Grants, option exercises and tax withholding are not counted.
How did David Badawi's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and David Badawi has 0.
Where does David Badawi file Form 4?
David Badawi has filed Form 4 at SGHT (Sight Sciences, Inc.) as Chief Technology Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.